Dashboard
Manage Tickers

NVONOVO NORDISK A S

NYSE novonordisk.com


$ 135.18 $ 2.25 (1.69 %)    

Tuesday, 21-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 0.89 (0.2 %)
DIA $ 398.57 $ 0.68 (0.17 %)
SPY $ 530.36 $ 1.30 (0.25 %)
TLT $ 91.26 $ 0.47 (0.52 %)
GLD $ 225.37 $ -0.33 (-0.15 %)
$ 135.16
$ 133.37
$ 0.00 x 0
$ 0.00 x 0
$ 133.37 - $ 135.42
$ 74.66 - $ 137.29
3,559,763
na
609,572
$ 0.65
$ 0.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

exclusive-roundhill-investments-launches-weight-loss-etf-for-exposure-to-blockbuster-drugs-like-ozempic
EXCLUSIVE: Roundhill Investments Launches ...
05/21/2024 20:33:05

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and c...

the-ozempic-diet-nestle-launches-5-pizza-for-weight-loss-drug-users
The Ozempic Diet: Nestle Launches $5 Pizza...
05/21/2024 18:25:52

Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, an...

novo-nordisk-ceo-says-catalent-deal-will-bring-three-large-sites-to-co-and-theres-ample-expansion-opportunity-on-those-sites-in-addition-to-catalent-sites-co-will-continue-working-with-contract-manufacturers-there-are-a-lot-of-contract-manufacturers-knocking-our-door-almost-on-a-weekly-basis
Novo Nordisk CEO Says Catalent Deal Will B...
05/21/2024 14:54:50

- Reuters

novo-nordisk-ceo-says-over-the-next-quarter-seeing-a-steady-flow-of-trial-data-for-semaglutide-when-we-now-launch-in-new-countries-we-want-to-do-it-in-a-way-where-we-set-aside-a-defined-capacity-for-obesity-drug-pleased-with-the-catalent-acquisition-that-were-now-working-on-and-we-expect-to-close-in-this-year
Novo Nordisk CEO Says "Over The Next Quart...
05/21/2024 14:54:25

- Reuters

novo-nordisk-ceo-on-compounded-versions-of-cos-drug-semaglutide-in-the-us-says-we-can-not-vouch-for-the-quality-of-those-medicines-co-is-conducting-a-large-phase-3-program-exploring-the-benefit-of-using-semaglutide-in-alzheimers-disease-expects-clinical-data-next-year-from-phase-3-program-of-semaglutide-in-alzheimers-disease
Novo Nordisk CEO On Compounded Versions Of...
05/21/2024 14:53:54

- Reuters

Core News & Articles
Novo Nordisk CEO, On Lilly's Diabetes Drug...
05/21/2024 14:53:10

- Reuters

novo-nordisk-ceo-says-co-is-conducting-a-large-phase-3-program-exploring-the-benefit-of-using-semaglutide-in-alzheimers-disease
Novo Nordisk CEO Says Co Is Conducting A L...
05/21/2024 14:17:41

eli-lilly-secures-china-nod-for-popular-weight-lossdiabetes-drug-tirzepatide
Eli Lilly Secures China Nod For Popular We...
05/21/2024 13:36:01

Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic....

wellness-platform-hims--hers-health-adds-glp-1-injections-for-weight-loss-stock-soars
Wellness Platform Hims & Hers Health Adds ...
05/20/2024 16:07:19

Hims & Hers Health expands its weight loss offerings with GLP-1 injections and oral medication kits. Pricing starts at $79/...

genetic-profile-key-to-novo-nordisks-wegovys-weight-loss-effectiveness-study-reveals
Genetic Profile Key To Novo Nordisk's Wego...
05/20/2024 13:34:13

Certain genes may predict strong responses to Novo Nordisk's Wegovy (semaglutide) in obesity treatment, with patients showi...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/17/2024 17:35:23

smart-money-is-betting-big-in-nvo-options
Smart Money Is Betting Big In NVO Options
05/17/2024 16:01:45

heres-how-much-you-would-have-made-owning-novo-nordisk-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
05/16/2024 20:30:24

13f-shows-soros-fund-management-llc-decreased-stake-in-novo-nordisk-a-s-by-75721k-shares-or--49-to-79762k-shares-valued-at-10241m
13F Shows Soros Fund Management LLC Decrea...
05/15/2024 21:11:19

no-wegovy-shortage-in-denmark-amid-high-demand-novo-nordisk-confirms
No Wegovy Shortage in Denmark Amid High De...
05/15/2024 15:59:08

Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines A...

eli-lilly-strikes-deal-to-combat-counterfeit-diabetes-and-weight-loss-drugs-mounjaro-and-zepbound
Eli Lilly Strikes Deal To Combat Counterfe...
05/15/2024 14:03:37

Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease us...

Core News & Articles
Eli Lilly Provides Update On Mounjaro And ...
05/14/2024 21:15:25

Core News & Articles
'Lilly Settles With Spa Selling Mounjaro, ...
05/14/2024 21:14:09

https://www.wsj.com/livecoverage/stock-market-today-dow-jones-05-14-2024/card/lilly-settles-with-spa-selling-mounjaro-zepbound-...

spotlight-on-novo-nordisk-analyzing-the-surge-in-options-activity
Spotlight on Novo Nordisk: Analyzing the S...
05/14/2024 17:15:41

novo-nordisks-wegovy-delivers-long-term-study-shows-sustained-weight-loss-as-drugmaker-tries-to-woo-insurers-and-governments
Novo Nordisk's Wegovy Delivers: Long-Term ...
05/14/2024 06:26:36

The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION